Cancer Cause and Prevention Research in New Jersey
Cancer Cause and Prevention Research (93.393) awarded $54.2 million to recipients in New Jersey in 38 grants from fiscal 2021 to 2025, 1.5% of the program's national total. Rutgers the State University of New Jersey received the most, $45.6 million.
- Awarded in New Jersey$54.2 million
- Awards38
- Share of the program1.5%
- Rank among states20th of 48
- National total$3.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 17 | $9.2 million |
| FY 2022 | 19 | $9.6 million |
| FY 2023 | 19 | $10.7 million |
| FY 2024 | 21 | $11.4 million |
| FY 2025 | 23 | $13.2 million |
Recipients in New Jersey
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Rutgers the State University of New Jersey | Colleges and universities | 26 | $45.6 million |
| HMH Hospitals Corporation | Nonprofits | 3 | $4.3 million |
| Rutgers, the State University of New Jersey | Colleges and universities | 3 | $2.3 million |
| Rutgers, the State University | Colleges and universities | 3 | $1.5 million |
| Rutgers, the State University | Colleges and universities | 1 | $399,283 |
| Ru School of Osteopathic Medicine | Colleges and universities | 1 | $80,500 |
| New Jersey Institute of Technology | Colleges and universities | 1 | $1,234 |
Open opportunities under this program
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 60 on the program page
Questions people ask
How much Cancer Cause and Prevention Research money goes to New Jersey?
$54.2 million from fiscal 2021 to 2025, across 38 awards. New Jersey ranks 20th of 48 states and territories for this program.
Who receives Cancer Cause and Prevention Research money in New Jersey?
The largest recipient is Rutgers the State University of New Jersey, with $45.6 million in 26 awards. Next are HMH Hospitals Corporation and Rutgers, the State University of New Jersey.
Can organizations in New Jersey apply now?
Yes, 60 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Cause and Prevention Research in other states
Other large programs in New Jersey
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Federal Transit Formula Grants
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- National School Lunch Program
- Children's Health Insurance Program
- Special Education Grants to States
- 1332 State Innovation Waivers
- Title I Grants to Local Educational Agencies